title: Severe neurotoxicity associated with dimethyl sulphoxide following PBSCT.
authors.forename: A
authors.initials: A
authors.lastname: Abdelkefi
authors.forename: A
authors.initials: A
authors.lastname: Lakhal
authors.forename: N
authors.initials: N
authors.lastname: Moojat
authors.forename: L Ben
authors.initials: LB
authors.lastname: Hamed
authors.forename: J
authors.initials: J
authors.lastname: Fekih
authors.forename: S
authors.initials: S
authors.lastname: Ladeb
authors.forename: L
authors.initials: L
authors.lastname: Torjman
authors.forename: T Ben
authors.initials: TB
authors.lastname: Othman
mesh_terms: D003451:Cryoprotective Agents / Q000009:adverse effects*; D004121:Dimethyl Sulfoxide / Q000009:adverse effects*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D016896:Treatment Outcome
chemical_list: D003451:Cryoprotective Agents; D004121:Dimethyl Sulfoxide